- Research Grants
graduation at Biomedicina from Universidade Paulista (2011), master's at Pathological Anatomy and Clinical Pathology from Faculdade de Medicina de São José do Rio Preto (2013) and doctorate at Pathological Anatomy and Clinical Pathology from Faculdade de Medicina de São José do Rio Preto (2016). (Source: Lattes Curriculum)
Hypoxia is a known adverse factor in cancer treatment, able to activate signaling pathways MAPK and PI3K / Akt / mTOR, the two major pathways involved in the process of angiogenesis which is regulated by numerous factors, the most significant is the Hypoxia-Inducible Factor - 1 (HIF-1) and Vascular Endothelial Growth Factor (VEGF). The transcription factor HIF-1± is the major regulator ...
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
|Data from Web of Science|